Efficacy of rTMS and VCT on Upper Limb Function in Patients With Stroke

August 17, 2020 updated by: Chang Gung Memorial Hospital

Efficacy of Repetitive Transcranial Magnetic Stimulation and Virtual Cycling Training on Upper Limb Function in Patients With Stroke

Stroke is the major cause of motor impairment and physical disabilities in the adult population. Spasticity and loss of dexterity are the common problems in stroke. Recently, current interventions, such as cycling training, virtual reality (VR) and repetitive transcranial magnetic stimulation (rTMS), were used for the treatment of upper extremity (UE) dysfunction in patients with stroke. However, few studies investigated the effects of the combinations of different treatment strategies using by integrating brain imaging and motor control studies. This project proposes different novel treatment strategies in the treatment of UE dysfunction in patients with stroke: combined inhibitory/facilitatory rTMS, VR-based cycling training (VCT), and combined rTMS and VCT. We hypothesize that the treatment effect of the combined protocol (optimal rTMS protocol and VCT) is more effective than single treatment due to integration of central and peripheral effects. Different treatment protocols will induce different changes in the brain reorganization and motor control, which further improve motor function, activity, participation, and health related quality of life (HRQOL).

Study Overview

Detailed Description

This study aims to 1. identify the immediate effects of different treatment protocols in for UE training in these patients through brain image, motor control and clinical measures; 2. to determine the maintaining therapeutic effects; 3. to elucidate the most optimal treatment protocols; 4. to determine the neuro-motor control mechanism underlying clinical improvement; 5. to determine the clinimetric properties of the brain imaging and motor control measure that are responsive and valid for detecting changes after treatment protocol intervention, and 6. to identify clinical predictors influencing the outcome for treatment protocols.

The research will offer valuable motor control biomarkers for outcome prediction and targeting patients who benefit from new protocols. This project is significant for the translational and evidence-based medicine on stroke neurorehabilitation.

Study Type

Interventional

Enrollment (Anticipated)

120

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Taoyuan, Taiwan, 333
        • Recruiting
        • Chang Gung Memorial Hospital

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

20 years to 80 years (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • first stroke
  • chronic stroke (onset > 3 months)
  • unilateral cerebral lesion with hemiparesis or hemiplegia
  • age of 20-80 years
  • no epileptic spikes on the EEG

Exclusion Criteria:

  • brain stem or cerebellum stroke
  • epilepsy
  • aneurysm
  • arteriovenous malformation
  • psychiatric disease
  • degenerative disease
  • severe cognitive and communicative impairment or aphasia
  • severe medical disease
  • active medical problems
  • metal implant in the body
  • pregnancy
  • poor cooperation with assessments

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Double

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: iTBS group
In intermittent theta burst stimulation (iTBS group), they received iTBS (80% of active motor threshold) on affected hemisphere.

In intermittent theta burst stimulation pattern (iTBS) will intermittently give a 2 s train of TBS every 10s repeated 2 times for a total of 40 times (low pulse: 1200 pulses in total)

Other Names:

intermittent theta burst stimulation

Experimental: cTBS group
In continuous theta burst stimulation (cTBS group), they received cTBS (80% of active motor threshold) on unaffected hemisphere.

In continuous burst stimulation pattern (cTBS) will intermittently give a cTBS treatment consists of a continuous train of TBS for 40 seconds repeated for 2 times(low pulse: 1200 pulses in total).

Other Names:

continuous burst stimulation

Experimental: iTBS+cTBS group
Continuous theta burst stimulation (cTBS group) at first followed by intermittent theta burst stimulation (iTBS group).
In iTBS+cTBS pattern, continuous cTBS will be followed by intermittent iTBS (low pulse; 1200 pulses in total)
Sham Comparator: sham TBS group
In sham theta burst stimulation (sham TBS group), they received sham TBS stimulation.

In sham burst stimulation pattern (sham TBS) will intermittently give a sham TBS treatment consists of a continuous train of TBS for 40 seconds(almost no pulse: 1200 pulses in total).

Other Names:

sham theta burst stimulation

Experimental: VCT group
VCT group received the VCT training in addition to traditional rehabilitation. Each UE VCT session involved upper limb cycling training followed by UE training in addition to home program. The cycling program consisted of a warm-up exercise, twenty repetitions of hand push-up movements in the sitting position, UE cycling, and a cool-down exercise.

The UE VCT programs were conducted three times per week, for 12 weeks. Each UE VCT session involved upper limb cycling training followed by UE training in addition to home program. The cycling program consisted of a warm-up exercise, twenty repetitions of hand push-up movements in the sitting position, UE cycling, and a cool-down exercise. The warm-up and cool-down exercises involved stretching and relaxing the head, neck, and the upper and lower body.

Other Names:

The upper extremity programs virtual cycling training program

Experimental: VCT+optimal rTMS group
VCT+optimal rTMS group received the VCT training and optimal rTMS in addition to traditional rehabilitation.
In VCT+optimal rTMS group, VCT will be combined with optimal rTMS, which has the best outcome in phase 1.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change from baseline of mechanical measurement for stroke after 3 weeks treatment and 3 months follow-up
Time Frame: baseline, after 3 weeks of treatment, 3 months
Kinematic analysis for upper limb
baseline, after 3 weeks of treatment, 3 months
Change from baseline of severity for stroke after 3 weeks treatment and 3 months follow-up
Time Frame: baseline, after 3 weeks of treatment, 3 months
Brunnstrom stage classification(by severity from stage 1 to stage 6), Modified Ashworth Scale (tension of upper limb from min(0) to max (4)) and National Institute of Health Stroke Scale (severity from min(0) to max(4))
baseline, after 3 weeks of treatment, 3 months
Change from baseline of Muscle tone measurement for stroke after 3 weeks treatment and 3 months follow-up
Time Frame: baseline, after 3 weeks of treatment, 3 months
Muscle tone
baseline, after 3 weeks of treatment, 3 months
Change from baseline of Muscle strength measurement for stroke after 3 weeks treatment and 3 months follow-up
Time Frame: baseline, after 3 weeks of treatment, 3 months
Muscle strength
baseline, after 3 weeks of treatment, 3 months

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change from baseline of body composition for stroke in after 3 weeks treatment and 3 months follow-up
Time Frame: baseline, after 3 weeks of treatment, 3 months
InBodyS10 Body Composition Analyzer
baseline, after 3 weeks of treatment, 3 months
Change from baseline of activity for stroke in after 3 weeks treatment and 3 months follow-up
Time Frame: baseline, after 3 weeks of treatment, 3 months
Barthel Index
baseline, after 3 weeks of treatment, 3 months
Change from baseline of ABAS for stroke in after 3 weeks treatment and 3 months follow-up
Time Frame: baseline, after 3 weeks of treatment, 3 months
Adaptive behavior assessment system
baseline, after 3 weeks of treatment, 3 months
Change from baseline of quality of life for stroke in after 3 weeks treatment and 3 months follow-up
Time Frame: baseline, after 3 weeks of treatment, 3 months
Stroke Impact Scale
baseline, after 3 weeks of treatment, 3 months
Change from baseline of WMFT for stroke in after 3 weeks treatment and 3 months follow-up
Time Frame: baseline, after 3 weeks of treatment, 3 months
Wolf motor function test
baseline, after 3 weeks of treatment, 3 months
Change from baseline of MAL for stroke in after 3 weeks treatment and 3 months follow-up
Time Frame: baseline, after 3 weeks of treatment, 3 months
Motor activity log
baseline, after 3 weeks of treatment, 3 months
Change from baseline of TUG for stroke in after 3 weeks treatment and 3 months follow-up
Time Frame: baseline, after 3 weeks of treatment, 3 months
Timed 'Up & Go' test
baseline, after 3 weeks of treatment, 3 months
Change from baseline of FIM for stroke in after 3 weeks treatment and 3 months follow-up
Time Frame: baseline, after 3 weeks of treatment, 3 months
Functional Independence Measure
baseline, after 3 weeks of treatment, 3 months
Change from baseline of participation for stroke in after 3 weeks treatment and 3 months follow-up
Time Frame: baseline, after 3 weeks of treatment, 3 months
Nottingham Health Profile
baseline, after 3 weeks of treatment, 3 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

August 1, 2016

Primary Completion (Anticipated)

February 11, 2022

Study Completion (Anticipated)

May 31, 2022

Study Registration Dates

First Submitted

September 7, 2017

First Submitted That Met QC Criteria

November 20, 2017

First Posted (Actual)

November 22, 2017

Study Record Updates

Last Update Posted (Actual)

August 18, 2020

Last Update Submitted That Met QC Criteria

August 17, 2020

Last Verified

January 1, 2020

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Cerebral Vascular Accident

Clinical Trials on intermittent theta burst stimulation

Subscribe